Cargando…

Influenza vaccination: protecting the most vulnerable

Influenza virus infection causes seasonal epidemics and occasional pandemics, leading to huge morbidity and mortality worldwide. Vaccination against influenza is needed annually as protection from constantly mutating strains is required. Groups at high risk of poor outcomes include the elderly, the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tanner, Alex R., Dorey, Robert B., Brendish, Nathan J., Clark, Tristan W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2021
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488965/ https://www.ncbi.nlm.nih.gov/pubmed/33650528 http://dx.doi.org/10.1183/16000617.0258-2020

Ejemplares similares

Physical distancing in schools for SARS-CoV-2 and the resurgence of rhinovirus
por: Poole, Stephen, et al.
Publicado: (2020)

Increase in circulation of non-SARS-CoV-2 respiratory viruses following easing of social distancing is associated with increasing hospital attendance
por: Tanner, Alex R, et al.
Publicado: (2021)

SARS-CoV-2 viral load at presentation to hospital is independently associated with the risk of death
por: Tanner, Alex R, et al.
Publicado: (2021)

Routine molecular point-of-care testing for SARS-CoV-2 reduces hospital-acquired COVID-19
por: Livingstone, Robert, et al.
Publicado: (2022)

SARS-CoV-2 has displaced other seasonal respiratory viruses: Results from a prospective cohort study
por: Poole, Stephen, et al.
Publicado: (2020)

Molecular point-of-care testing for respiratory viruses versus routine clinical care in adults with acute respiratory illness presenting to secondary care: a pragmatic randomised controlled trial protocol (ResPOC)
por: Brendish, Nathan J., et al.
Publicado: (2017)

Point-of-care testing for respiratory viruses in adults: The current landscape and future potential
por: Brendish, Nathan J., et al.
Publicado: (2015)

654. Evaluation of the Febridx Host Response Point-of-Care Test to Differentiate Viral From Bacterial Etiology in Adults Hospitalized with Acute Respiratory Illness During Influenza Season
por: Beard, Kate, et al.
Publicado: (2019)

2796. The Impact of Syndromic Molecular Point-of-Care Testing for Respiratory Viruses on Antibiotic Use in Adults Presenting to Hospital with Exacerbation of Airways Disease: Further Analysis From a Randomized Controlled Trial
por: Clark, Tristan William, et al.
Publicado: (2019)

Impact of point-of-care testing for respiratory viruses on antibiotic use in adults with exacerbation of airways disease
por: Brendish, Nathan J., et al.
Publicado: (2019)

Pragmatic multicentre randomised controlled trial evaluating the impact of a routine molecular point-of-care ‘test-and-treat’ strategy for influenza in adults hospitalised with acute respiratory illness (FluPOC): trial protocol
por: Beard, Kate, et al.
Publicado: (2019)

1717. The Impact of Routine Molecular Point-of-care Testing for Gastrointestinal Pathogens in Adults Hospitalized With Suspected Gastroenteritis: Results of a Pragmatic Randomized Controlled Trial (GastroPOC)
por: Malachira, Ahalya, et al.
Publicado: (2018)

Podocytes—The Most Vulnerable Renal Cells in Preeclampsia
por: Kwiatkowska, Ewa, et al.
Publicado: (2020)

Combined RT-PCR and Host Response Point-of-Care Testing in Patients Hospitalised with Suspected COVID-19: A Prospective Diagnostic Accuracy Study
por: Brendish, Nathan J., et al.
Publicado: (2022)

Must We Vaccinate the Most Vulnerable? Efficiency, Priority, and Equality in the Distribution of Vaccines
por: Curran, Emma J., et al.
Publicado: (2022)

Are vaccines against COVID-19 tailored to the most vulnerable people?
por: Antonelli Incalzi, Raffaele, et al.
Publicado: (2021)

FebriDx host response point-of-care testing improves patient triage for coronavirus disease 2019 (COVID-19) in the emergency department
por: Mansbridge, Christopher T., et al.
Publicado: (2022)

FebriDx host response point-of-care testing improves patient triage for coronavirus disease 2019 (COVID-19) in the emergency department – ADDENDUM
por: Mansbridge, Christopher T., et al.
Publicado: (2022)

Remote Ischemic Conditioning for Anthracycline Cardiotoxicity: The Need to Protect the Most Vulnerable
por: Ibáñez, Borja, et al.
Publicado: (2023)

Should we vaccinate the better seroconverters or the most vulnerable? Game changing insights for COVID-19 vaccine prioritization policies
por: AbdelMassih, Antoine, et al.
Publicado: (2021)

The Most Vulnerable Leaders in the Community
por: Rissman, Lauren
Publicado: (2021)

Vaccinating to Protect a Vulnerable Subpopulation
por: Dushoff, Jonathan, et al.
Publicado: (2007)

Vaccine apartheid: the separation of the world’s poorest and most vulnerable and the birth of Omicron
por: Prasad, Sakshi, et al.
Publicado: (2022)

Pain Management in the Most Vulnerable Intellectual Disability: A Review
por: El-Tallawy, Salah N., et al.
Publicado: (2023)

A Public Health Paradox: The Women Most Vulnerable to Malaria Are the Least Protected
por: González, Raquel, et al.
Publicado: (2016)

Phased Implementation of COVID-19 Vaccination: Rapid Assessment of Policy Adoption, Reach and Effectiveness to Protect the Most Vulnerable in the US
por: Li, Yun, et al.
Publicado: (2021)

Antibody Focusing to Conserved Sites of Vulnerability: The Immunological Pathways for ‘Universal’ Influenza Vaccines
por: Sangesland, Maya, et al.
Publicado: (2021)

Clinical impact of a routine, molecular, point-of-care, test-and-treat strategy for influenza in adults admitted to hospital (FluPOC): a multicentre, open-label, randomised controlled trial
por: Clark, Tristan W, et al.
Publicado: (2021)

120. Impact of a Molecular Point-of-care ‘test and Treat’ Strategy for Influenza in Hospitalised adults: A Multi-centre, Randomised Controlled Trial (FluPOC)
por: Clark, Tristan William, et al.
Publicado: (2020)

Multimonth Dispensing of Antiretroviral Therapy Protects the Most Vulnerable From 2 Pandemics at Once
por: Traub, Ariana Moriah, et al.
Publicado: (2020)

Using Digital Data to Protect and Promote the Most Vulnerable in the Fight Against COVID-19
por: Chunara, Rumi, et al.
Publicado: (2020)

Neonatal anesthesia: how we manage our most vulnerable patients
por: Bang, Si Ra
Publicado: (2015)

Breast Cancer Care in California and Ontario: Primary Care Protections Greatest Among the Most Socioeconomically Vulnerable Women Living in the Most Underserved Places
por: Gorey, Kevin M., et al.
Publicado: (2017)

Trauma Transitional Care Coordination: protecting the most vulnerable trauma patients from hospital readmission
por: Hall, Erin C, et al.
Publicado: (2018)

Altruistic responses to the most vulnerable involve sensorimotor processes
por: Vickers, Brian D., et al.
Publicado: (2023)

Editorial: Vaccination of Special Populations: Protecting the Vulnerable
por: O’Connor, Daniel, et al.
Publicado: (2021)

Adjuvantation of Influenza Vaccines to Induce Cross-Protective Immunity
por: Li, Zhuofan, et al.
Publicado: (2021)

Influenza B: Prospects for the Development of Cross-Protective Vaccines
por: Tsybalova, Liudmila M., et al.
Publicado: (2022)

COVID-19 in the least developed, fragile, and conflict-affected countries — How can the most vulnerable be protected?
por: Ebrahim, Shahul H., et al.
Publicado: (2021)

Which Stratum of Urban Elderly Is Most Vulnerable for Dementia?
por: Moon, Yeonsil, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_mrhr7sfb6uh4rsi6ll9kio466o